Rockefeller Lists "Concerns" With Final Senate Finance Committee Bill
This article was originally published in The Pink Sheet Daily
The legislative language of the Senate Finance Committee bill was released Oct. 19 with a 13-page laundry list of concerns by Rockefeller.
You may also be interested in...
The independent Medicare Commission that would be established by the Senate Finance Committee's health reform bill would be specifically authorized to recommend cuts in the Part D program to help control government spending
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.